Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Two drug companies have attacked a decision to remove their treatments from a fund designed to give access to expensive therapies in England.
The Cancer Drugs Fund is overspent and 42 drugs are being reassessed as price caps are brought in for the first time.
Pharmaceutical companies say they are "outraged" at a "fundamentally flawed" decision that will damage patient care.
NHS England said the current system was unsustainable and that there were new drugs "that will do more for patients".
Drugs have to be cost-effective for the NHS to make them routinely available.
http://www.bbc.co.uk/news/health-30716205
The Cancer Drugs Fund is overspent and 42 drugs are being reassessed as price caps are brought in for the first time.
Pharmaceutical companies say they are "outraged" at a "fundamentally flawed" decision that will damage patient care.
NHS England said the current system was unsustainable and that there were new drugs "that will do more for patients".
Drugs have to be cost-effective for the NHS to make them routinely available.
http://www.bbc.co.uk/news/health-30716205